Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Interleukin-21 inhibits humoral response to an HIV DNA vaccine by enhancing Bcl-6 and Pax-5 expression.

Feng C, Jin J, Zou Q, Chen X, Zhou C, Wu B, Weiner DB, Wang B.

Viral Immunol. 2012 Apr;25(2):131-40. doi: 10.1089/vim.2011.0073.

PMID:
22486304
2.

Improvement in T helper 1-related immune responses in BALB/c mice immunized with an HIV-1 gag plasmid combined with a chimeric plasmid encoding interleukin-18 and flagellin.

Chen YL, Chen YS, Hung YC, Liu PJ, Tasi HY, Ni WF, Hseuh PT, Lin HH.

Microbiol Immunol. 2015 Aug;59(8):483-94. doi: 10.1111/1348-0421.12274.

3.

Soluble multi-trimeric TNF superfamily ligand adjuvants enhance immune responses to a HIV-1 Gag DNA vaccine.

Kanagavelu SK, Snarsky V, Termini JM, Gupta S, Barzee S, Wright JA, Khan WN, Kornbluth RS, Stone GW.

Vaccine. 2012 Jan 17;30(4):691-702. doi: 10.1016/j.vaccine.2011.11.088. Epub 2011 Dec 4.

4.

Increased level and longevity of protective immune responses induced by DNA vaccine expressing the HIV-1 Env glycoprotein when combined with IL-21 and IL-15 gene delivery.

Bolesta E, Kowalczyk A, Wierzbicki A, Eppolito C, Kaneko Y, Takiguchi M, Stamatatos L, Shrikant PA, Kozbor D.

J Immunol. 2006 Jul 1;177(1):177-91.

5.

Efficient augmentation of a long-lasting immune responses in HIV-1 gag DNA vaccination by IL-15 plasmid boosting.

Li W, Li S, Hu Y, Tang B, Cui L, He W.

Vaccine. 2008 Jun 19;26(26):3282-90. doi: 10.1016/j.vaccine.2008.03.081. Epub 2008 Apr 18.

PMID:
18472194
6.

Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.

Abaitua F, Rodríguez JR, Garzón A, Rodríguez D, Esteban M.

Virus Res. 2006 Mar;116(1-2):11-20. Epub 2005 Oct 7.

PMID:
16214252
7.

Interleukin-22 as a molecular adjuvant facilitates IL-17-producing CD8+ T cell responses against a HBV DNA vaccine in mice.

Wu B, Zou Q, Hu Y, Wang B.

Hum Vaccin Immunother. 2013 Oct;9(10):2133-41. doi: 10.4161/hv.26047. Epub 2013 Aug 13.

8.

HIV/SIV DNA vaccine combined with protein in a co-immunization protocol elicits highest humoral responses to envelope in mice and macaques.

Li J, Valentin A, Kulkarni V, Rosati M, Beach RK, Alicea C, Hannaman D, Reed SG, Felber BK, Pavlakis GN.

Vaccine. 2013 Aug 12;31(36):3747-55. doi: 10.1016/j.vaccine.2013.04.037. Epub 2013 Apr 26.

9.

Novel HIV IL-4R antagonist vaccine strategy can induce both high avidity CD8 T and B cell immunity with greater protective efficacy.

Jackson RJ, Worley M, Trivedi S, Ranasinghe C.

Vaccine. 2014 Sep 29;32(43):5703-14. doi: 10.1016/j.vaccine.2014.08.023. Epub 2014 Aug 20.

12.

Mucosal and systemic anti-GAG immunity induced by neonatal immunization with HIV LAMP/gag DNA vaccine in mice.

Goldoni AL, Maciel M Jr, Rigato PO, Piubelli O, de Brito CA, Melo A, Marques ET, August JT, Duarte AJ, Sato MN.

Immunobiology. 2011 Apr;216(4):505-12. doi: 10.1016/j.imbio.2010.08.007. Epub 2010 Sep 25.

PMID:
20870310
13.

Immunization with multiple vaccine modalities induce strong HIV-specific cellular and humoral immune responses.

Hallengärd D, Applequist SE, Nyström S, Maltais AK, Marovich M, Moss B, Earl P, Nihlmark K, Wahren B, Bråve A.

Viral Immunol. 2012 Oct;25(5):423-32. doi: 10.1089/vim.2012.0046.

PMID:
23035853
14.

Protective efficacy of Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) adjuvated with recombinant IL-15 and IL-21 against experimental toxoplasmosis in mice.

Chen J, Li ZY, Huang SY, Petersen E, Song HQ, Zhou DH, Zhu XQ.

BMC Infect Dis. 2014 Sep 6;14:487. doi: 10.1186/1471-2334-14-487.

15.

Induction of gp120-specific protective immune responses by genetic vaccination with linear polyethylenimine-plasmid complex.

Garzón MR, Berraondo P, Crettaz J, Ochoa L, Vera M, Lasarte JJ, Vales A, Van Rooijen N, Ruiz J, Prieto J, Zulueta J, González-Aseguinolaza G.

Vaccine. 2005 Feb 3;23(11):1384-92.

PMID:
15661387
16.

Co-administration of interleukins 7 and 15 with DNA vaccine improves protective immunity against Toxoplasma gondii.

Chen J, Li ZY, Petersen E, Liu WG, Zhu XQ.

Exp Parasitol. 2016 Mar;162:18-23. doi: 10.1016/j.exppara.2015.12.013. Epub 2015 Dec 17.

PMID:
26706605
17.

HIV-1 DNA vaccine efficacy is enhanced by coadministration with plasmid encoding IFN-alpha.

Jiang W, Ren L, Jin N.

J Virol Methods. 2007 Dec;146(1-2):266-73. Epub 2007 Sep 14.

PMID:
17868910
18.
19.

Enhancement of immune responses to an HIV env DNA vaccine by a C-terminal segment of listeriolysin O.

Bu Z, Ye L, Skeen MJ, Ziegler HK, Compans RW, Yang C.

AIDS Res Hum Retroviruses. 2003 May;19(5):409-20.

PMID:
12803999
20.

Topical application of HIV DNA vaccine with cytokine-expression plasmids induces strong antigen-specific immune responses.

Liu LJ, Watabe S, Yang J, Hamajima K, Ishii N, Hagiwara E, Onari K, Xin KQ, Okuda K.

Vaccine. 2001 Oct 12;20(1-2):42-8.

PMID:
11567744

Supplemental Content

Support Center